Status:
UNKNOWN
Intrapartum Maternal Glycemic Control Using Insulin Pump Versus Insulin Drip - Cohort Observational Trial
Lead Sponsor:
Sheba Medical Center
Conditions:
Pregestational Diabetes
Eligibility:
FEMALE
18-50 years
Brief Summary
The purpose of this study is to compare intrapartum glycemic control using insulin pump versus intravenous (IV) insulin administration.
Detailed Description
Intrapartum maternal glycemic control in women suffering from pregestational diabetes mellitus type 1 will be evaluated and compared in the 3 study groups. Maternal and neonatal capillary blood glucos...
Eligibility Criteria
Inclusion
- Pregnant women suffering from pregestational diabetes mellitus type-1,
- Women are being treated for a minimum of 3 months in the high risk pregnancy clinic in Sheba medical center
- Women are being treated with either insulin pump or SC insulin (basal-bolus)
Exclusion
- Women not compliant to treatment
- Women not planning their delivery in our institute
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2012
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT01158040
Start Date
August 1 2010
End Date
August 1 2012
Last Update
July 29 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Ramat Gan, Israel, 52621